MTHFR (methylenetetrahydrofolate reductase) C677T polymorphism and psoriasis

被引:0
|
作者
Vladimir Vasku
Julie Bienertova-Vasku
Miroslav Necas
Anna Vasku
机构
[1] Masaryk University Brno,1st Department of Dermatology, St. Ann’s Faculty Hospital
[2] Masaryk University,Department of Pathophysiology, Faculty of Medicine
来源
关键词
MTHFR; Polymorphism; Psoriasis; Folate; DNA methylation;
D O I
暂无
中图分类号
学科分类号
摘要
The aim of the study was to evaluate possible association of MTHFR C677T gene polymorphism (NM_005957) with psoriasis. Genotypes of MTHFR C677T gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. Case group (n = 410) included patients with psoriasis (plaque psoriasis diagnosed in 285 patients, other subtypes of psoriasis were observed in 125 patients). Control group (n = 244) consisted of healthy subjects without individual history of psoriasis, with similar age and gender characteristics. The MTHFR C677T polymorphism genotypes were determined by a polymerase chain reaction and a subsequent restriction analysis with HinfI. The genotypes of C(677)T methylenetetrahydrofolate reductase (MTHFR) gene polymorphism were determined in a sample of 654 Caucasian (Czech) subjects. We proved a significant difference in genotype distribution (Pg = 0.03) and allelic frequency (Pa = 0.02) between psoriatic and control subjects (Table 3). The CC (the thermostabile) genotype was significantly more frequent in psoriatic patients compared to controls [OR = 1.55, 95% confidential interval (CI) = 1.12–2.15, P = 0.004814, Pcorr = 0.01]. But, a significant increase of T allele in MTHFR gene was observed in patients with positive family history of diabetes (Pa = 0.02) and in those with a frequent tonsillitis/tonsillectomy (Pa = 0.04). No difference was observed between patients with and without positive family history of psoriasis (Pa = 0.251). But, when psoriatic patients were described for FHDM, FH-Ps, and PH-T simultaneously, The highest incidence of CT + TT genotypes was calculated for psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy compared to patients without all these three phenotypes (odds ratio = 3.17, 95% CI 1.33–7.56, Pcorr = 0.04). In conclusion, MTHFR C677T polymorphism is marginally associated with psoriasis. The T allele (thermolabile) appears to be more frequent in psoriasis patients with positive history of psoriasis and diabetes mellitus together with personal history of repeated tonsillitis/tonsillectomy. This could reflect an inborn predisposition in complex regulation in one-carbon moieties transport in psoriatic patients and therefore, MTHFR genotype can be a part of genetic background of psoriasis.
引用
收藏
页码:327 / 331
页数:4
相关论文
共 50 条
  • [21] Is the C677T methylenetetrahydrofolate reductase (MTHFR) polymorphism a risk factor for osteoporosis? A pilot study
    Whittle, C. R.
    Strain, J. J.
    Ward, M.
    Molloy, A. M.
    Scott, J. M.
    McCandless, A. S.
    McNulty, H.
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2007, 66 : 33A - 33A
  • [22] Association Between Methylenetetrahydrofolate Reductase (MTHFR) C677T Polymorphism and Age of Onset in Schizophrenia
    Vares, Maria
    Saetre, Peter
    Deng, Hong
    Cai, Guiqing
    Liu, Xiehe
    Hansen, Thomas
    Rasmussen, Henrik B.
    Werge, Thomas
    Melle, Ingrid
    Djurovic, Srdjan
    Andreassen, Ole A.
    Agartz, Ingrid
    Hall, Hakan
    Terenius, Lars
    Jonsson, Erik G.
    AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2010, 153B (02) : 610 - 618
  • [23] Methylenetetrahydrofolate reductase C677T polymorphism and pregnancy complications
    Stonek, Felix
    Hafner, Erich
    Philipp, Karl
    Hefler, Lukas A.
    Bentz, Eva-Katrin
    Tempfer, Clemens B.
    OBSTETRICS AND GYNECOLOGY, 2007, 110 (02): : 363 - 368
  • [24] C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses
    H Kunugi
    R Fukuda
    M Hattori
    T Kato
    M Tatsumi
    T Sakai
    T Hirose
    S Nanko
    Molecular Psychiatry, 1998, 3 : 435 - 437
  • [25] Association of methylenetetrahydrofolate reductase (C677T) polymorphism with hyperuricemia
    Golbahair, Jamal
    Aminzadeh, Mohammad A.
    Al-Shboul, Qasim M.
    Kassab, Salah
    Rezaian, Golam R.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2007, 17 (06) : 462 - 467
  • [26] Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy
    Vandana Rai
    Pradeep Kumar
    Neurological Sciences, 2018, 39 : 2033 - 2041
  • [27] Is methylenetetrahydrofolate reductase C677T polymorphism associated with hyperuricemia?
    Fan, Shujun
    Yang, Boyi
    Zhi, Xueyuan
    Wang, Yanxun
    Wei, Jian
    Sun, Guifan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2016, 9 (07): : 7518 - +
  • [28] No association of the C677T methylenetetrahydrofolate reductase polymorphism with schizophrenia
    Philibert, Robert
    Gunter, Tracy
    Hollenbeck, Nancy
    Adams, William J.
    Bohle, Phillip
    Packer, Hans
    Sandhu, Harinder
    PSYCHIATRIC GENETICS, 2006, 16 (05) : 221 - 223
  • [29] Methylenetetrahydrofolate reductase C677T polymorphism and susceptibility to epilepsy
    Rai, Vandana
    Kumar, Pradeep
    NEUROLOGICAL SCIENCES, 2018, 39 (12) : 2033 - 2041
  • [30] C677T polymorphism in methylenetetrahydrofolate reductase gene and psychoses
    Kunugi, H
    Fukuda, R
    Hattori, M
    Kato, T
    Tatsumi, M
    Sakai, T
    Hirose, T
    Nanko, S
    MOLECULAR PSYCHIATRY, 1998, 3 (05) : 435 - 437